BOLD Q3 2017 Earnings — Boundless Bio, Inc. Revenue & Financial Results | Market Cap Arena

BOLDBoundless Bio, Inc.

$26M

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$66M

Net Income

-$66M

EPS (Diluted)

$-2.59

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$26M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$200M

Total Liabilities

$25M

Stockholders' Equity

$175M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$66M	-$40M	-64.9%
Net Income	-$66M	-$40M	-64.7%